- Home
- CYRX vs RXST Comparison
CYRX vs RXST Comparison
Compare CYRX & RXST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CYRX
- RXST
- Stock Information
- Founded
- CYRX 1999
- RXST 1997
- Country
- CYRX United States
- RXST United States
- Employees
- CYRX N/A
- RXST N/A
- Industry
- CYRX Biotechnology: Pharmaceutical Preparations
- RXST Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- CYRX Health Care
- RXST Health Care
- Exchange
- CYRX Nasdaq
- RXST Nasdaq
- Market Cap
- CYRX 438.7M
- RXST 365.8M
- IPO Year
- CYRX N/A
- RXST 2021
- Fundamental
- Price
- CYRX $8.87
- RXST $8.96
- Analyst Decision
- CYRX Strong Buy
- RXST Hold
- Analyst Count
- CYRX 10
- RXST 11
- Target Price
- CYRX $11.70
- RXST $11.80
- AVG Volume (30 Days)
- CYRX 578.2K
- RXST 1.0M
- Earning Date
- CYRX 11-06-2025
- RXST 11-06-2025
- Dividend Yield
- CYRX N/A
- RXST N/A
- EPS Growth
- CYRX N/A
- RXST N/A
- EPS
- CYRX 1.35
- RXST N/A
- Revenue
- CYRX $237,879,000.00
- RXST $147,059,000.00
- Revenue This Year
- CYRX N/A
- RXST N/A
- Revenue Next Year
- CYRX $9.08
- RXST $6.71
- P/E Ratio
- CYRX $6.57
- RXST N/A
- Revenue Growth
- CYRX 24.93
- RXST 27.68
- 52 Week Low
- CYRX $4.58
- RXST $6.32
- 52 Week High
- CYRX $10.46
- RXST $57.53
- Technical
- Relative Strength Index (RSI)
- CYRX 50.42
- RXST 49.96
- Support Level
- CYRX $8.53
- RXST $9.10
- Resistance Level
- CYRX $10.46
- RXST $9.54
- Average True Range (ATR)
- CYRX 0.58
- RXST 0.53
- MACD
- CYRX -0.10
- RXST 0.02
- Stochastic Oscillator
- CYRX 31.76
- RXST 34.18
About CYRX CryoPort Inc.
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.
About RXST RxSight Inc.
RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture and sale of light adjustable lenses and related capital equipment.